Cargando…
Antimicrobial peptides: A promising tool to combat multidrug resistance in SARS CoV2 era
COVID-19 (Coronavirus Disease 2019), a life-threatening viral infection, is caused by a highly pathogenic virus named SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2). Currently, no treatment is available for COVID-19; hence there is an urgent need to find effective therapeutic drugs to...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier GmbH.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491010/ https://www.ncbi.nlm.nih.gov/pubmed/36162150 http://dx.doi.org/10.1016/j.micres.2022.127206 |
_version_ | 1784793204619476992 |
---|---|
author | Saini, Jasleen Kaur, Pritpal Malik, Naveen Lakhawat, Sudarshan Singh Sharma, Pushpender Kumar |
author_facet | Saini, Jasleen Kaur, Pritpal Malik, Naveen Lakhawat, Sudarshan Singh Sharma, Pushpender Kumar |
author_sort | Saini, Jasleen |
collection | PubMed |
description | COVID-19 (Coronavirus Disease 2019), a life-threatening viral infection, is caused by a highly pathogenic virus named SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2). Currently, no treatment is available for COVID-19; hence there is an urgent need to find effective therapeutic drugs to combat COVID-19 pandemic. Considering the fact that the world is facing a major issue of antimicrobial drug resistance, naturally occurring compounds have the potential to achieve this goal. Antimicrobial peptides (AMPs) are naturally occurring antimicrobial agents which are effective against a wide variety of microbial infections. Therefore, the use of AMPs is an attractive therapeutic strategy for the treatment of SARS-CoV-2 infection. This review sheds light on the potential of antimicrobial peptides as antiviral agents followed by a comprehensive description of effective antiviral peptides derived from various natural sources found to be effective against SARS-CoV and other respiratory viruses. It also highlights the mechanisms of action of antiviral peptides with special emphasis on their effectiveness against SARS-CoV-2 infection. |
format | Online Article Text |
id | pubmed-9491010 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier GmbH. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94910102022-09-21 Antimicrobial peptides: A promising tool to combat multidrug resistance in SARS CoV2 era Saini, Jasleen Kaur, Pritpal Malik, Naveen Lakhawat, Sudarshan Singh Sharma, Pushpender Kumar Microbiol Res Article COVID-19 (Coronavirus Disease 2019), a life-threatening viral infection, is caused by a highly pathogenic virus named SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2). Currently, no treatment is available for COVID-19; hence there is an urgent need to find effective therapeutic drugs to combat COVID-19 pandemic. Considering the fact that the world is facing a major issue of antimicrobial drug resistance, naturally occurring compounds have the potential to achieve this goal. Antimicrobial peptides (AMPs) are naturally occurring antimicrobial agents which are effective against a wide variety of microbial infections. Therefore, the use of AMPs is an attractive therapeutic strategy for the treatment of SARS-CoV-2 infection. This review sheds light on the potential of antimicrobial peptides as antiviral agents followed by a comprehensive description of effective antiviral peptides derived from various natural sources found to be effective against SARS-CoV and other respiratory viruses. It also highlights the mechanisms of action of antiviral peptides with special emphasis on their effectiveness against SARS-CoV-2 infection. Elsevier GmbH. 2022-12 2022-09-21 /pmc/articles/PMC9491010/ /pubmed/36162150 http://dx.doi.org/10.1016/j.micres.2022.127206 Text en © 2022 Elsevier GmbH. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Saini, Jasleen Kaur, Pritpal Malik, Naveen Lakhawat, Sudarshan Singh Sharma, Pushpender Kumar Antimicrobial peptides: A promising tool to combat multidrug resistance in SARS CoV2 era |
title | Antimicrobial peptides: A promising tool to combat multidrug resistance in SARS CoV2 era |
title_full | Antimicrobial peptides: A promising tool to combat multidrug resistance in SARS CoV2 era |
title_fullStr | Antimicrobial peptides: A promising tool to combat multidrug resistance in SARS CoV2 era |
title_full_unstemmed | Antimicrobial peptides: A promising tool to combat multidrug resistance in SARS CoV2 era |
title_short | Antimicrobial peptides: A promising tool to combat multidrug resistance in SARS CoV2 era |
title_sort | antimicrobial peptides: a promising tool to combat multidrug resistance in sars cov2 era |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491010/ https://www.ncbi.nlm.nih.gov/pubmed/36162150 http://dx.doi.org/10.1016/j.micres.2022.127206 |
work_keys_str_mv | AT sainijasleen antimicrobialpeptidesapromisingtooltocombatmultidrugresistanceinsarscov2era AT kaurpritpal antimicrobialpeptidesapromisingtooltocombatmultidrugresistanceinsarscov2era AT maliknaveen antimicrobialpeptidesapromisingtooltocombatmultidrugresistanceinsarscov2era AT lakhawatsudarshansingh antimicrobialpeptidesapromisingtooltocombatmultidrugresistanceinsarscov2era AT sharmapushpenderkumar antimicrobialpeptidesapromisingtooltocombatmultidrugresistanceinsarscov2era |